Vicarious Surgical (RBOT) Stock Overview
Engages in the development and sale of single-port surgical robot in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
RBOT Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Vicarious Surgical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.20 |
| 52 Week High | US$13.75 |
| 52 Week Low | US$0.27 |
| Beta | 1.56 |
| 1 Month Change | -34.07% |
| 3 Month Change | -45.70% |
| 1 Year Change | -85.19% |
| 3 Year Change | -98.24% |
| 5 Year Change | -99.59% |
| Change since IPO | -99.59% |
Recent News & Updates
Recent updates
Long-Term Robotic Surgery Adoption And Design Freeze Milestones Will Support A Bullish Thesis
Catalysts About Vicarious Surgical Vicarious Surgical is developing a robotic surgical system designed for minimally invasive procedures. What are the underlying business or industry changes driving this perspective?Here's Why We're A Bit Worried About Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation
Jul 15
Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Deliver On Growth Plans?
Mar 18We're Keeping An Eye On Vicarious Surgical's (NYSE:RBOT) Cash Burn Rate
Nov 30Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely
Aug 16Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Mar 05Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Nov 24Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization
Aug 24Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation
Jul 18Vicarious Surgical: Cash Burn Adds To Downside Risk
May 26Vicarious Surgical Non-GAAP EPS of -$0.16 beats by $0.02
Feb 13Vicarious Surgical Non-GAAP EPS of -$0.18 misses by $0.03
Nov 07Shareholder Returns
| RBOT | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 185.7% | -1.8% | -2.2% |
| 1Y | -85.2% | -10.3% | 16.5% |
Return vs Industry: RBOT underperformed the US Medical Equipment industry which returned -8.2% over the past year.
Return vs Market: RBOT underperformed the US Market which returned 19.4% over the past year.
Price Volatility
| RBOT volatility | |
|---|---|
| RBOT Average Weekly Movement | 38.5% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: RBOT's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: RBOT's weekly volatility has increased from 23% to 39% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 26 | Stephen From | www.vicarioussurgical.com |
Vicarious Surgical Inc. engages in the development and sale of single-port surgical robot in the United States. The company offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. Vicarious Surgical Inc. was founded in 2014 and is headquartered in Waltham, Massachusetts.
Vicarious Surgical Inc. Fundamentals Summary
| RBOT fundamental statistics | |
|---|---|
| Market cap | US$7.12m |
| Earnings (TTM) | -US$50.18m |
| Revenue (TTM) | n/a |
Is RBOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RBOT income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$50.18m |
| Earnings | -US$50.18m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.04 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 5.3% |
How did RBOT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/18 13:38 |
| End of Day Share Price | 2026/03/18 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vicarious Surgical Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adam Maeder | Piper Sandler Companies |